Related Experiment Videos
Is ammonia a pathogenetic factor in Alzheimer's disease?
Neurochemical Research
|March 1, 1993
Summary
Ammonia may contribute to Alzheimer's disease (dementia of the Alzheimer type) progression. Elevated ammonia levels in the brain cause dysfunction, impacting neurotransmission and protein processing, suggesting potential therapeutic targets.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Dementia of the Alzheimer type (DAT) is a progressive neurodegenerative disorder.
- The role of ammonia in DAT pathogenesis is increasingly investigated.
- Hyperammonemia is linked to various brain dysfunctions.
Purpose of the Study:
- To review experimental evidence supporting ammonia's role in DAT.
- To explore biochemical and cellular mechanisms of ammonia's impact on the brain.
Main Methods:
- Review of existing experimental data on ammonia and DAT.
- Analysis of biochemical and cellular changes associated with hyperammonemia in DAT brains.
Main Results:
- Hyperammonemia induces brain dysfunctions including astrocytosis, impaired glucose utilization, and altered energy metabolism.
- Ammonia affects neurotransmission, increasing excitability and glutamate release.
- Ammonia may interfere with lysosomal protein processing, relevant to amyloid precursor protein metabolism.
Conclusions:
- Ammonia is not a primary cause but a contributing factor to DAT manifestations and progression.
- Elevated ammonia levels in DAT patients warrant consideration for therapeutic interventions.
- Targeting ammonia levels could offer novel strategies for ameliorating DAT symptoms and slowing disease progression.